Recursion Pharmaceuticals, Inc.
RXRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $594,350 | $391,565 | $549,912 | $285,116 |
| Short-Term Investments | $0 | $0 | $0 | $231,446 |
| Receivables | $49,166 | $3,094 | $2,753 | $9,090 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $70,753 | $43,478 | $17,149 | $9,066 |
| Total Curr. Assets | $714,269 | $438,137 | $569,814 | $534,718 |
| Property Plant & Equip (Net) | $233,213 | $120,173 | $121,447 | $64,725 |
| Goodwill | $148,873 | $52,056 | $801 | $801 |
| Intangibles | $335,855 | $36,443 | $1,306 | $1,385 |
| Long-Term Investments | $5,629 | $0 | $0 | $0 |
| Tax Assets | $1,934 | $0 | $0 | $0 |
| Other NC Assets | $8,825 | $6,890 | $7,920 | $8,716 |
| Total NC Assets | $734,329 | $215,562 | $131,474 | $75,627 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,448,598 | $653,699 | $701,288 | $610,345 |
| Liabilities | – | – | – | – |
| Payables | $21,613 | $3,953 | $4,586 | $2,819 |
| Short-Term Debt | $22,220 | $6,157 | $6,049 | $1,506 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $61,767 | $36,426 | $56,726 | $10,000 |
| Other Curr. Liab. | $81,872 | $46,635 | $32,904 | $32,333 |
| Total Curr. Liab. | $187,472 | $93,171 | $100,265 | $46,658 |
| LT Debt | $86,272 | $44,515 | $44,956 | $9,972 |
| Deferred Rev, NC | $118,765 | $51,238 | $70,261 | $6,667 |
| Deferred Tax Liab, NC | $16,575 | $1,339 | $0 | $0 |
| Other NC Liab. | $4,732 | $0 | $0 | $4,110 |
| Total NC Liab. | $226,344 | $97,092 | $115,217 | $20,749 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $67,250 | $49,530 | $50,372 | $10,755 |
| Total Liabilities | $413,816 | $190,263 | $215,482 | $67,407 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $2 | $2 | $2 |
| Retained Earnings | -$1,431,283 | -$967,622 | -$639,556 | -$400,080 |
| AOCI | -$7,637 | $0 | $0 | -$126 |
| Other Equity | $2,473,698 | $1,431,056 | $1,125,360 | $943,142 |
| Total Equity | $1,034,782 | $463,436 | $485,806 | $542,938 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,448,598 | $653,699 | $701,288 | $610,345 |
| Net Debt | -$485,858 | -$340,893 | -$498,907 | -$273,638 |